FNAC for Diagnosis - the very basic for ALL –

Slides:



Advertisements
Similar presentations
SOFT TISSUE TUMORS Prof Hesham Saad.
Advertisements

Module 6: Clinical Stage and Grade. Introduction Stage and grade determine prognosis Staging reflects the clinical extent of the tumor Grading a tumor.
1 Cytologic Features of Urothelial Carcinoma in Catheterized Urine with Cellular Fragments 萬芳醫院 陳嘉偉 Mohamed El-Fakharany, M.D. et al. ACTA CYTOLOGICA May-June.
July 21, year old female. Thin prep pap A) Reactive endocervical cells B) HSIL C) LSIL D) Squamous metaplasia E) ASCUS 1.
Neoplasia 1: Introduction. terminology oncology: the study of tumors neoplasia: new growth (indicates autonomy with a loss of response to growth controls)
Cytology Training Program: Gyn Cytology Revision Exercise by Tony Chan
Hologic Proprietary © 2012 ThinPrep ® Pap Test Diagnostic Challenges and Differential Diagnoses.
Minimally Invasive Follicular Carcinoma: A Cytological and Histological Challenge David Poller, Queen Alexandra Hospital,Portsmouth, UK.
Procedures used by CHTN
Neoplasia Lecture 2 Dr. Maha Arafah.
Precancerous lesion of FGT
Salivary Gland Pathology. Structural elements of the salivary gland unit. pleomorphic adenomas originate from the intercalated duct cells and myoepithelial.
بسم الله الرحمن الرحيم. Interpretation of urine cytology Nashwa Emara M.D.,phd ASS. Prof. Pathology.
Section 2 Atypia.
FNA of breast Slide session The 6th Arab-British School of Pathology
IN THE NAME OF GOD FIN GARDEN KASHAN. FNA of the Parotid gland In a 22 y/o woman Case 1:
A 75 y/o woman with Solitary hypo function cold nodule of upper pole of right lobe.
Neoplasia p.1 SYLLABUS: RBP(Robbins Basic Pathology) Chapter: Neoplasia Definitions Nomenclature Characteristics of benign and malignant neoplasms Epidemiology.
Case Study 45 Julia Kofler, M.D.. Clinical history: 41 year old male with a 2 year history of progressive hypopituitarism, headache and bitemporal hemianopsia.
Cytopathology. 7 Dr. Maha Al-Sedik 2015 CLS Neoplasm. 2- Stages of carcinoma. 3- Differences between benign and malignant neoplasm. 4- Dysplasia.
Dr. Osama I Nassif. MD, FRCPC. Associate professor & consultant pathologist. Pathology Dept. King Abdulaziz University. NEOPLASIA بسم الله الرحمن الرحيم.
Endocrine practical block Dr Shaesta Naseem
Malignant Mesothelioma in Effusions and Fine Needle Aspirates No relationship exists that represents a possible conflict of interest with respect to the.
March 13, y/o female. FNA of thyroid. 1 Hashimoto’s thyroiditis Lymphocytes mixed with follicular cells.
Educational case 1 Dr JD Hemming Queen Elizabeth Hospital Gateshead.
KCP 784 경희대학교병원 병리과 박재영. Clinical History  F/54  20여 일간 지속된 폐경 후 질 출혈을 주소로 내원  2010년 자궁경부 생검에서 Mild dysplasia (CIN 1) 진단  이 후 추적 검사(Pap smear)에서 특이.
KCP-760 ( 토 의 자 ) 원 자 력 병 원 전공의 허일영. Male / 75 Chief complaint: Chest pain on exertion for 6 months Chest CT: Pleural effusion with diffuse pleural thickening.
KCP 763 (Pleural fliud) 서울대학교병원 전공의 남경한.  10 세 남자  재태 연령 37 주 정상 질 분만으로 출생  2010 년 전신 긴장성 발작 (generalized tonic seizure) 발생  뇌 자기공명영상 (MRI) 에서 후두엽의.
NEOPLASIA Dr. Manal Maher Hussein.
A 39 year old woman presented with a well-defined 1X1.5 cm nodule in the lower pole of the thyroid which was hypoecho in sonography. FNA with Giemsa stain.
KCP 797 강남세브란스병원박혜성. 33/M, Cervical lymphadenopathy: R/O TB, R/O nonspecific lymphadenopathy R/O TB, R/O nonspecific lymphadenopathy.
인하대병원 전공의 최창환. Clinical history  33 세, 남자  좌측 경부 콩알크기 종괴 (1 개월전 )  U/S: 좌측 level I, II, III, IV 에 커진 림프절 ( 최 대 3.1cm)  결핵성 림프절염 혹은 비특이적 림프절염 의 심하.
KCP-786 KCP-786 서울대학교 병원 전공의 백해운. History 59 세 (Gravida5, Para2) 2007 년 HPV18(+) 이후 자궁질 도말검사를 수 차례 받음 Op Hx : 2011 년 담낭결석, 2010 년 복압 요실금 기타 특이사항 없음 2012.
Glandular lesion and Iatrogenic lesion
KCP792 79/ 여자, 자궁경부 / 흉수 성균관의대 병리학교실 강북삼성병원 병리과 채승완.
KCP 748 (P ) 고려대학교 구로병원 서울대학교 병원 R4 김효진 대한세포병리학회 4 월 월례집담회.
KCP 810 울산대학교 서울아산병원 병리과 전공의 송인혜. 환자 병력 40 세 / 여자 17 년 전 오른쪽 이하선 종양으로 부분절제 8 년 전 전절제, 방사선 치료 이후 재발 및 재수술 반복 경부 MRI 및 PET: 오른쪽 빗장위림프절 전이 의심 림프절 세포흡인검사.
KCP 774 경북대학교병원 병리과 전공의 박보은. M/28 좌측 전 종격동에 약 5.6 cm 크기의 종괴 좌측 폐문부와 하엽, 중엽에도 결절 두꺼워진 엽간격막 좌측 두정엽에 부종과 출혈을 동반한 병변 α fetoprotein 20,051.0 ng/ml, CEA 7.5.
Clinical presentation of parotid gland tumors
44.
Interesting Case Presentation Written by: Neil Blackwell This case was provided by: GynaePath – Douglass Hanly Moir Pathology, Sydney, Australia.
KCP 788 가톨릭중앙의료원 전공의 서성욱. Clinical History F/39 특이 병력 없음 건강검진시 부인과 이상소견 자궁경부 세포학검사 후 원추절제술 및 자궁 절제술 시행 슬라이드는 자궁경부 액상도말표본.
KCP-800 삼성서울병원 전공의 2년차 방희진.
KCP 791 삼성서울병원 전공의 신유주. Patient history F/58 On chemotherapy (due to breast cancer) Carotid doppler ultrasound (follow up) –Thyroid nodule Ultrasonography.
Chien-Chin Chen1,2(陳建欽), Yi-Jun Jian1
KCP-815 서울대학교 병원 전공의 최은오.
KCP 794 인하대병원 전공의 최창환.
Medullary Thyroid Carcinoma
Ultrasound breast core needle biopsy
CASE STUDY Dr. Alireza Azimi 92/10/21.
Pulmonary hamartoma Here are two examples of a benign lung neoplasm known as a pulmonary hamartoma. These uncommon lesions appear on chest radiograph as.
CHARACTERISTICS OF BENIGN AND MALIGNANT TUMORS
THYROID.
CLASSIFICATION OF TUMORS
History 58 year-old female presented with back pain and right toe numbness. Her past medical history was significant for hypertension, glaucoma and.
Case Study 44 Julia Kofler, M.D..
The most common origin of cervical squamous cell carcinoma
Cytopathology-8 DR. MAHA AL-SEDIK.
Thickening of intima (atherosclerotic plaque) due to proliferation of cholesterol-containing macrophages and other cells Thrombus formed due to atherosclerotic.
Department of Pathology
Acta Cytologica 2015;59: DOI: /
Cytological changes in abnormal conditions
Case Study 41 Henry Armah, M.D., M.Phil..
Acta Cytologica 2014;58: DOI: /
Case Study 34 Henry Armah, M.D., M.Phil..
Pleomorphic Adenoma Benign Mixed Tumor.
Peter Kulesza, Isam A. Eltoum  Clinical Gastroenterology and Hepatology 
AMR Seminar Symposium Split, Croatia Case #63
Case Study 15 Gabrielle Yeaney, M.D..
Case 1 :Intraoperative FNA and biopsy of the pancreas
Presentation transcript:

FNAC for Diagnosis - the very basic for ALL – 16Jun2018 Dr Lam Wing Yin Consultant Pathologist Tuen Mun Hospital

How to Evaluate your FNA smear ensure Everything examined always starts with direct eyeballing 4X POWER examination is crucial Do not forget the smear/glass edges

5 main attributes to assess Cellularity The cellular composition in the aspirate The architecture (cell arrangement) of the aspirated cells Cytomorphology of the lesion cells The slide background

Cellularity Benign tumor lesions tend to be hypocellular Malignant tumor FNA showed high cellularity Exceptions always

Cellular composition in the aspirate answer the following Qns: Is there only 1 cell type in the smear 1 cell type in general = from a Neoplasm N.B. 1 cell type can be uniform or polymorphic Are there >1 cell types in the smear; are they from same tissue, or from different sources? Some tumors showed >1 cell type (e.g. Pleom Adenoma, Synovial SA, MMMT) Is there a mixture of benign & Malignant cells ( prostate CA, 2*CA in LN0)

Cellular Patterns and Architecture i.e. = How cells are arranged in the aspirate/smears Degree of cohesiveness is crucial Often, this is the clue to Benignity vs Malignancy

Cell pattern/Architure (2) Dispersive cell pattern Glandular, with lumina Acinar / Rosettes Fragments with demarcated borders Papillary Cell balls Cell balls with fenestrations (cribriform) Trabecular (thick or thin) Fascicular Mixed (squamous and glands; epithelial and lymphoid; spindle and epithelioid etc)

CytoMorphology Nuclear alterations basically indicates benignity vs malignancy (exceptions+) Cytoplasmic textures and staining indicate the function and type of the cells

CytoMorphology (1) Exceptional scenarios Nuclear alterations often indicates benignity vs malignancy (exceptions+) Nuclear enlargement ( & N/C ratio) Nuclear size and shape variation Nuclear membrane irregularity Nuclear chromasia Nuclear chromatin irregularity Macronucleoli Abnormal mitosis Exceptional scenarios Degenerative cells (schwannoma), RT/CT effect, endocrine tumors, pleomorphic mesenchymal tumor

CytoMorphology (2) Cytoplasmic textures and staining indicate the function and type of the cells Squamous cells Malignant columnar cells Vacuolated cells (nuclear compression?) Polygonal cells + Granular cells Small round cells Plasmacytoid cells Spindle cells bizarre cells Nuclear grooving; macronucleoli Cytoplasmic granules, pigments, inclusions, lipid & glycoen

Smear Background Diathesis vs clean Mucin Stromal substances (fibromyxoid fragments, fibrillary material, colloid) psammomas

5 main attributes to assess Cellularity The cellular composition in the aspirate The architecture (cell arrangement) of the aspirated cells Cytomorphology of the lesion cells The slide background

Reporting (1) Remember your report may be Definitive and Final for Mx 5 Classes-system is simple and often practical C1: inadequate, non diagnostic, unsatisfactory C2: benign C3: atypical, Indeterminate, IDK C4: suspicious C5: diagnostic malignant Additional information needed for management Confirming a suspected DIAGNOSIS, or excluding a Dx Recommending Treatment (if deem necessary), or indicate further Investigations/additional information

Reporting (2) If a Histologic confirmation is need, say so in the report If no definitive diagnosis, suggest your differential diagnosis according to their likelihood For a ‘NEGATIVE’, best to clearly state it is to mean The lesion is a benign lesion, or There are only normal cells intrinsic to the site aspirated. The report should be formulated with due CLINICOPATHOLOGIC CORRELATION, understanding of the clinical implication & attention to Diagnostic Pitfalls (F-ve/F+ve).

END THANK YOU